UK Markets open in 2 hrs 40 mins

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8900-0.0600 (-2.03%)
At close: 04:00PM EST
2.7300 -0.16 (-5.54%)
After hours: 07:36PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.9500
Bid2.8800 x 2200
Ask2.9200 x 1000
Day's range2.8500 - 2.9990
52-week range2.8500 - 7.3400
Avg. volume874,693
Market cap451.43M
Beta (5Y monthly)1.99
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    2 Cancer Stocks With Absurdly Low Valuations

    The potential for four or more interest rate hikes by the Federal Reserve over the course of 2022 has been weighing heavily on growth stocks of late. Investors are clearly pivoting toward safe havens like value and dividend stocks ahead of this perceived eventuality. Shares of the cancer specialists Adaptimmune Therapeutics (NASDAQ: ADAP) and Clovis Oncology (NASDAQ: CLVS) are both trading at absurdly low valuations following their steep downturns over the past several weeks.

  • Zacks

    4 Biotechs That Could Be Potential Takeover Targets in 2022

    We discuss a few companies like BioMarin (BMRN), Adaptimmune (ADAP), CRISPR Therapeutics (CRSP), and Alnylam Pharmaceuticals (ALNY) with solid product portfolios, deep pipelines which make them attractive candidates for a potential takeover in 2022.

  • Motley Fool

    Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November

    A mix of marketwide headwinds and company-specific events weighed on these three biotech stocks in November.